1Lazzarino M, Orlandi E, Klersy C, et al. Serum CA125 is of clinical value in the staging and follow- up of patients with non- Hodgkin's lymphoma: correlation with tumor parameters and disease activity[J]. Cancer, 1998,82:576-582.
2O'Rourke J, Mahon S M. A comprehensive look at the early detection of ovarian cancer[J]. Clin J Oncol Nurs, 2003, 7:41-47.
3Camera A,Villa M R,Rocco S,et al. IncreasedCA125serumlevels in patients with advanced acute leukemia with serosal involvement[J]. Cancer,2000,88:75-78.
4Lawicki S, Mroczko B. Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms[J]. Postepy Hig Med Dosw, 2002,56:617 -634.
5Kubonishi I, Bandobashi K, Murata N, et al. High serum levels of CA125 and interleukin-6 in a patient with lKi- 1 lymphoma[J]. Br J Hematol, 1997,98:450-452.
6Pecdersen L M, Milman N. Microalbuminuria in patients with lung cancer[J]. Eur J Cancer, 1998,34:76-80.
7Camera A,Villa M R, Rocco S, et al. Increasecd CA125 serum levels in patients with advancecd acute leukemia with serosal involvement [J]. Cancer ,2000,88:75-78.
8Apel R L, Fernandes B J. Malignant lymphoma presenting with an elevated serum CA125 level[J]. Arch Pathol Lab Med, 1995,119:373 -376.
8L. Benboubker,C. Valat,C. Linassier,G. Cartron,M. Delain,M. Bout,F. Fetissof,T. Lefranq,J. P. Lamagnere,Ph. Colombat. A new serologic index for low-grade non-Hodgkin’s lymphoma based on initial CA125 and LDH serum levels[J] 2000,Annals of Oncology(11):1485～1491
